Logo image
Feasibility study on dosimetry verification of volumetric‐modulated arc therapy‐based total marrow irradiation
Journal article   Open access   Peer reviewed

Feasibility study on dosimetry verification of volumetric‐modulated arc therapy‐based total marrow irradiation

Yun Liang, Gwe‐Ya Kim, Todd Pawlicki, Arno J. Mundt and Loren K. Mell
Journal of applied clinical medical physics, v 14(2), pp 15-23
Mar 2013
PMID: 23470926
url
https://europepmc.org/articles/pmc5714362View
Published, Version of Record (VoR)Open Access (License Unspecified) Open
url
https://doi.org/10.1120/jacmp.v14i2.3852View
Published, Version of Record (VoR) Open

Abstract

Radiation Oncology Physics
The purpose of this study was to develop dosimetry verification procedures for volumetric‐modulated arc therapy (VMAT)‐based total marrow irradiation (TMI). The VMAT based TMI plans were generated for three patients: one child and two adults. The planning target volume (PTV) was defined as bony skeleton, from head to mid‐femur, with a 3 mm margin. The plan strategy similar to published studies was adopted. The PTV was divided into head and neck, chest, and pelvic regions, with separate plans each of which is composed of 2–3 arcs/fields. Multiple isocenters were evenly distributed along the patient's axial direction. The focus of this study is to establish a dosimetry quality assurance procedure involving both two‐dimensional (2D) and three‐dimensional (3D) volumetric verifications, which is desirable for a large PTV treated with multiple isocenters. The 2D dose verification was performed with film for gamma evaluation and absolute point dose was measured with ion chamber, with attention to the junction between neighboring plans regarding hot/cold spots. The 3D volumetric dose verification used commercial dose reconstruction software to reconstruct dose from electronic portal imaging devices (EPID) images. The gamma evaluation criteria in both 2D and 3D verification were 5% absolute point dose difference and 3 mm of distance to agreement. With film dosimetry, the overall average gamma passing rate was 98.2% and absolute dose difference was 3.9% in junction areas among the test patients; with volumetric portal dosimetry, the corresponding numbers were 90.7% and 2.4%. A dosimetry verification procedure involving both 2D and 3D was developed for VMAT‐based TMI. The initial results are encouraging and warrant further investigation in clinical trials. PACS number: 87.55.Qr

Metrics

13 Record Views
11 citations in Scopus

Details

UN Sustainable Development Goals (SDGs)

This publication has contributed to the advancement of the following goals:

#3 Good Health and Well-Being

InCites Highlights

Data related to this publication, from InCites Benchmarking & Analytics tool:

Collaboration types
Domestic collaboration
Web of Science research areas
Radiology, Nuclear Medicine & Medical Imaging
Logo image